A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory Neuroblastoma
Clinical trial NCT06438614 · COMPLETED
Trial details
- NCT number
- NCT06438614
- Sponsor
- Fundació Sant Joan de Déu
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-20
- Primary completion
- 2023-07-20
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.